Diabetes, Vol 44, Issue 7 739-743, Copyright © 1995 by American Diabetes Association

ARTICLES

Unchanged incidence of diabetic nephropathy in IDDM patients

P Rossing, K Rossing, P Jacobsen and HH Parving
Steno Diabetes Center, Gentofte, Denmark.

Recently, a dramatic decline in the cumulative incidence of diabetic nephropathy (< 10% after 25 years of diabetes) has been reported in insulin-dependent diabetes mellitus (IDDM) patients diagnosed before the age of 15 years between 1961 and 1980. In a clinic-based study, we assessed recent trends in the incidence of diabetic nephropathy. All 356 patients in whom IDDM was diagnosed before the age of 41 years between 1965 and 1979, identified in 1984, were followed until 1991 or until death. All patients were Caucasians and resided in Copenhagen. The cumulative incidences (life-table method) of diabetic nephropathy (urinary albumin excretion > or = 300 mg/24 h in two out of three consecutive samples) after 15 years of diabetes and in 1991 were 18 +/- 4 and 35 +/- 5% (cumulative incidence +/- SE; onset of diabetes 1965-1969, n = 113), 20 +/- 4 and 35 +/- 5% (onset of diabetes 1970-1974, n = 130), and 16 +/- 5% (onset of diabetes 1975-1979, n = 113), respectively (NS at 15 years). The prevalence of persistent microalbuminuria (31-299 mg/24 h) at time of follow-up was 24% (95% confidence interval: 16-33) in the group with onset of diabetes in 1965-1969, 28% (20-36) with onset of diabetes in 1970-1974, and 19% (13-28) with onset of diabetes in 1975-1979 (NS). The mean +/- SE HbA1c measured yearly beginning in 1984 was higher in patients with nephropathy (9.4 +/- 0.1%) and persistent microalbuminuria (8.9 +/- 0.1%) than in patients with normoalbuminuria (8.5 +/- 0.1%; P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Aaltonen, J. Rinta-Valkama, A. Patari, P. Tossavainen, T. Palmen, P. Kulmala, M. Knip, and H. Holthofer Circulating antibodies to nephrin in patients with type 1 diabetes Nephrol. Dial. Transplant., January 1, 2007; 22(1): 146 - 153. [Abstract] [Full Text] [PDF]

				G. Pambianco, T. Costacou, D. Ellis, D. J. Becker, R. Klein, and T. J. Orchard The 30-year natural history of type 1 diabetes complications: the pittsburgh epidemiology of diabetes complications study experience. Diabetes, May 1, 2006; 55(5): 1463 - 1469. [Abstract] [Full Text] [PDF]

				C. Cao, J. P. Hellermann, M. Weber, and P. M. Ambuhl Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades Nephrol. Dial. Transplant., March 1, 2006; 21(3): 770 - 775. [Abstract] [Full Text] [PDF]

				M. Svensson, L. Nystrom, S. Schon, G. Dahlquist, and on behalf of the Swedish Childhood Diabetes Study Age at Onset of Childhood-Onset Type 1 Diabetes and the Development of End-Stage Renal Disease: A nationwide population-based study. Diabetes Care, March 1, 2006; 29(3): 538 - 542. [Abstract] [Full Text] [PDF]

				E. Galkina and K. Ley Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377. [Abstract] [Full Text] [PDF]

				F. Mohsin, M. E Craig, J. Cusumano, A. K.F. Chan, S. Hing, J. W. Lee, M. Silink, N. J. Howard, and K. C. Donaghue Discordant Trends in Microvascular Complications in Adolescents With Type 1 Diabetes From 1990 to 2002 Diabetes Care, August 1, 2005; 28(8): 1974 - 1980. [Abstract] [Full Text] [PDF]

				T. B. Torbjornsdotter, G. A. Jaremko, and U. B. Berg Nondipping and Its Relation to Glomerulopathy and Hyperfiltration in Adolescents With Type 1 Diabetes Diabetes Care, February 1, 2004; 27(2): 510 - 516. [Abstract] [Full Text] [PDF]

				K. V. Allen and J. D. Walker Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes Diabetes Care, August 1, 2003; 26(8): 2389 - 2391. [Abstract] [Full Text] [PDF]

				P. Hovind, L. Tarnow, K. Rossing, P. Rossing, S. Eising, N. Larsen, C. Binder, and H.-H. Parving Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes Diabetes Care, April 1, 2003; 26(4): 1258 - 1264. [Abstract] [Full Text] [PDF]

				P. Hovind, P. Rossing, L. Tarnow, and H.-H. Parving Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes Diabetes Care, March 1, 2003; 26(3): 911 - 916. [Abstract] [Full Text] [PDF]

				D. M. Nathan The Impact of Clinical Trials on the Treatment of Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 1929 - 1937. [Abstract] [Full Text] [PDF]

				M. Mauer and K. Drummond The Early Natural History of Nephropathy in Type 1 Diabetes: I. Study Design and Baseline Characteristics of the Study Participants Diabetes, May 1, 2002; 51(5): 1572 - 1579. [Abstract] [Full Text] [PDF]

				M. P. Madaio and J. T. Harrington The Diagnosis of Glomerular Diseases: Acute Glomerulonephritis and the Nephrotic Syndrome Arch Intern Med, January 8, 2001; 161(1): 25 - 34. [Abstract] [Full Text] [PDF]

				D. KOYA, M. HANEDA, H. NAKAGAWA, K. ISSHIKI, H. SATO, S. MAEDA, T. SUGIMOTO, H. YASUDA, A. KASHIWAGI, D. K. WAYS, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC {beta} inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J, March 1, 2000; 14(3): 439 - 447. [Abstract] [Full Text]

				F.P. Dunne, T.A. Chowdhury, A Hartland, T. Smith, P.A. Brydon, C. McConkey, and H.O. Nicholson Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy QJM, August 1, 1999; 92(8): 451 - 454. [Abstract] [Full Text] [PDF]